Get started
Author

Rachel P. Riechelmann

Observed names: Rachel P Riechelmann, Rachel Riechelmann, Riechelmann, Rachel P, Riechelmann, Rachel P.
Institution: AC Camargo Hospital
Observed institution: AC Camargo Hospital
ORCID: 0000-0002-0107-9617
Observed ORCID: 0000-0002-0107-9617
OpenAlex ID: A5126471378
Germline Pathogenic Variants in Patients With Early Onset Neuroendocrine Neoplasms
2022 · Rachel Riechelmann, Rachel P. Riechelmann, et al. · Brazilian Journal of Oncology · 15
Beyond Convenience: Does Subcutaneous Pembrolizumab Add Value for Patients and Health Systems?
2026 · Laure-Anne Teuwen, Rachel P. Riechelmann, et al. · Journal of Clinical Oncology · 1
Neoadjuvant therapy versus upfront surgery followed by adjuvant chemotherapy in resectable or borderline resectable PDAC: a systematic review and meta-analysis of RCTs
2026 · Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, et al. · Therapeutic Advances in Medical Oncology
Efficacy and Safety of Once-Daily Oral Paltusotine in Patients with Carcinoid Syndrome: Results from a Phase 2 Multicentre Study
2026 · Aman Chauhan, Amr Mohamed, et al. · SSRN Electronic Journal
Access to Diagnosis and Treatments for Patients With Neuroendocrine Tumors in Brazil
2021 · Carla Rodrigues Dias, Renata D'Alpino Peixoto, et al. · Brazilian Journal of Oncology
Health Resource Utilization by Patients With Neuroendocrine Tumors With or Without Carcinoid Heart Disease
2019 · Hugo Tanaka, Hugo Tanaka, et al. · Brazilian Journal of Oncology
Works count: 12
Citation count: 17
H-index: 1
I10-index: 1
Year
Topic
Type